Biopharmaceuticals
News Release - June 22, 2006
Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the European Rheumatology Meeting
Source: Targeted Genetics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.